Brazil · Delayed Price · Currency is BRL CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of BRL 521.58 billion. The enterprise value is 878.31 billion.
| Market Cap | 521.58B |
| Enterprise Value | 878.31B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 21, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 89.83% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 53.56 and the forward PE ratio is 11.06.
| PE Ratio | 53.56 |
| Forward PE | 11.06 |
| PS Ratio | 0.24 |
| PB Ratio | 1.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.13 |
| P/OCF Ratio | 8.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.70, with an EV/FCF ratio of 20.43.
| EV / Earnings | 90.19 |
| EV / Sales | 0.43 |
| EV / EBITDA | 9.70 |
| EV / EBIT | 17.08 |
| EV / FCF | 20.43 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.84 |
| Quick Ratio | 0.57 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 4.53 |
| Debt / FCF | 10.24 |
| Interest Coverage | 3.21 |
Financial Efficiency
Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.
| Return on Equity (ROE) | 2.29% |
| Return on Assets (ROA) | 2.47% |
| Return on Invested Capital (ROIC) | 5.62% |
| Return on Capital Employed (ROCE) | 6.08% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | 8.49M |
| Profits Per Employee | 37,527 |
| Employee Count | 259,500 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 18.56 |
Taxes
In the past 12 months, CVS Health has paid 2.25 billion in taxes.
| Income Tax | 2.25B |
| Effective Tax Rate | 19.10% |
Stock Price Statistics
The stock price has increased by +10.56% in the last 52 weeks. The beta is 0.50, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +10.56% |
| 50-Day Moving Average | 41.66 |
| 200-Day Moving Average | 39.41 |
| Relative Strength Index (RSI) | 51.78 |
| Average Volume (20 Days) | 1,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.97 |
Income Statement
In the last 12 months, CVS Health had revenue of BRL 2.20 trillion and earned 9.74 billion in profits. Earnings per share was 7.66.
| Revenue | 2.20T |
| Gross Profit | 292.63B |
| Operating Income | 55.18B |
| Pretax Income | 11.77B |
| Net Income | 9.74B |
| EBITDA | 80.55B |
| EBIT | 55.18B |
| Earnings Per Share (EPS) | 7.66 |
Balance Sheet
The company has 58.37 billion in cash and 440.36 billion in debt, with a net cash position of -381.99 billion.
| Cash & Cash Equivalents | 58.37B |
| Total Debt | 440.36B |
| Net Cash | -381.99B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 415.20B |
| Book Value Per Share | 325.95 |
| Working Capital | -76.99B |
Cash Flow
In the last 12 months, operating cash flow was 58.60 billion and capital expenditures -15.60 billion, giving a free cash flow of 43.00 billion.
| Operating Cash Flow | 58.60B |
| Capital Expenditures | -15.60B |
| Free Cash Flow | 43.00B |
| FCF Per Share | n/a |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.
| Gross Margin | 13.29% |
| Operating Margin | 2.51% |
| Pretax Margin | 0.53% |
| Profit Margin | 0.44% |
| EBITDA Margin | 3.66% |
| EBIT Margin | 2.51% |
| FCF Margin | 1.95% |
Dividends & Yields
This stock pays an annual dividend of 0.98, which amounts to a dividend yield of 2.40%.
| Dividend Per Share | 0.98 |
| Dividend Yield | 2.40% |
| Dividend Growth (YoY) | -3.02% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 192.14% |
| Buyback Yield | -0.71% |
| Shareholder Yield | 1.69% |
| Earnings Yield | 1.87% |
| FCF Yield | 8.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 21, 2022. It was a forward split with a ratio of 5.
| Last Split Date | Nov 21, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 7 |